Albert Cha, M.D., Ph.D. is a Managing Partner and joined the firm in 2000. His focus is to invest in later-stage private and public companies.
He serves on the boards of Biodel (NASDAQ: BIOD) and Bioform Medical (NASDAQ: BFRM) as well as several private biotechnology and medical device companies. Albert has gained valuable operational experience by serving as founding or interim CEO for several portfolio companies. Prior to joining Vivo, Albert worked at Oracle Corporation in pharmaceutical consulting and at the Palo Alto VA Hospital as a biomedical engineer.
Graduating from Stanford University with a B.S. and M.S. in Electrical Engineering, Albert went on to complete an M.D. and Ph.D. in Neuroscience from UCLA Medical School. During his studies, he was elected to Alpha Omega Alpha and won the prestigious Outstanding Graduate Student Award. His research in molecular biophysics has been published in highly respected journals such as Nature and Neuron.
|